Clinical trial
A Phase II Randomized Trial of High-Intensity Aerobic Interval Training and Surrogate Markers of Cardiovascular Disease in a Population-based Sample of Testicular Cancer Survivors
NCT02459132 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized Trial of High-Intensity Aerobic Interval Training and Surrogate Markers of Cardiovascular Disease in a Population-based Sample of Testicular Cancer Survivors
- Lead sponsor
- University of Alberta
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- April 30, 2017
- Enrollment
- 63 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.